Loss‐Framed Financial Incentives and Personalized Goal‐Setting to Increase Physical Activity Among Ischemic Heart Disease Patients Using Wearable Devices: The ACTIVE REWARD Randomized Trial

Abstract

BackgroundRegular physical activity reduces the risk of cardiovascular events, but most ischemic heart disease (IHD) patients do not obtain enough.Methods and ResultsACTIVE REWARD (A Clinical Trial Investigating Effects of a Randomized Evaluation of Wearable Activity Trackers with Financial Rewards) was a 24‐week home‐based, remotely monitored, randomized trial with a 16‐week intervention (8‐week ramp‐up incentive phase and 8‐week maintenance incentive phase) and an 8‐week follow‐up. Patients used wearable devices to track step counts and establish a baseline. Patients in control received no other interventions. Patients in the incentive arm received personalized step goals and daily feedback for all 24 weeks. In the ramp‐up incentive phase, daily step goals increased weekly by 15% from baseline with a maximum of 10 000 steps and then remained fixed. Each week, $14 was allocated to a virtual account; $2 could be lost per day for not achieving step goals. The primary outcome was change in mean daily steps from baseline to the maintenance incentive phase. Ischemic heart disease patients had a mean (SD) age of 60 (11) years and 70% were male. Compared with control, patients in the incentive arm had a significantly greater increase in mean daily steps from baseline during ramp‐up (1388 versus 385; adjusted difference, 1061 [95% confidence interval, 386–1736]; P<0.01), maintenance (1501 versus 264; adjusted difference, 1368 [95% confidence interval, 571–2164]; P<0.001), and follow‐up (1066 versus 92; adjusted difference, 1154 [95% confidence interval, 282–2027]; P<0.01).ConclusionsLoss‐framed financial incentives with personalized goal setting significantly increased physical activity among ischemic heart disease patients using wearable devices during the 16‐week intervention, and effects were sustained during the 8‐week follow‐up.Clinical Trial Registration URL: https://www.clinicaltrials.gov. Unique identifier: NCT02531022.

The effectiveness of wearable technologies as physical activity interventions in weight control: A systematic review and meta‐analysis of randomized controlled trials

“…The main target of PA interventions is to reinforce intentions, decision‐making, problem‐solving, and self‐efficacy to encourage individuals to engage in PAs. Traditional approaches of PA motivation are paper‐based records for tracing activities, phone calls, or text messages to remind participants to exercise, face‐to‐face counselling by instructors, and financial incentives for participants' achievement …”

Characterisation of ICU sleep by a commercially available activity tracker and its agreement with patient-perceived sleep quality

“…10 12-14 Wearable technology such as research-grade actigraphy or other advanced activity watches show potential for various healthcare applications. 25 The Fitbit Charge 2 was chosen due to its potential for more broad application as it offers the advantage of widespread availability, low cost, favourable patient perception, ease of cleaning and potential for utilisation for other areas than sleep such as mobility (step) tracking both during and after the ICU stay. 20 21 When applied to a highly selected group of nonintubated adults, the Fitbit Charge 2 was able to characterise TST for all patients on all ICU nights.…”

The economic benefits of a more physically active population: An international analysis

“…Thus, it is not the presence of a financial incentive that is important but, rather, how that financial incentive is framed. Chokshi et al (2018) found that loss-framed financial incentives with personalised goal setting significantly increased physical activity among ischemic heart disease patients using wearable devices over the course of a 16-week intervention and that effects were sustained over the 8-week follow-up.…”